Top compounds associated with response to ZNF14


Feature Type Standardized
Nominal ANOVA
mRNA birinapant CTRPv2 pan-cancer AAC -0.061 0.1
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.056 0.1
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.076 0.1
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.061 0.1
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.1
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.055 0.1
mRNA CAY10603 GDSC1000 pan-cancer AAC 0.047 0.1
mRNA KIN001-102 GDSC1000 pan-cancer AAC 0.046 0.1
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.1
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC 0.049 0.1
Download CSV